ABCC7 p.Pro841Arg
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 20059485
[PubMed]
Dorfman R et al: "Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?"
No.
Sentence
Comment
64
Mutations in the CFTR gene grouped by clinical category Cystic fibrosis CFTR-related disease No disease T338I D614G L320V V920L L90S M470V H199R S1251N I203M G550R P111A I148T Q1291H R560K L1388Q L183I R170H I1027T S549R D443Y P499A L1414S T908N R668C S549N A455E E1401K Q151K G27E I1234L Y563N R347P C866R S1118C P1290S R75Q A559T V520F P841R M469V E1401G P67L G85E S50Y E1409K R933G G458V G178R Y1032C R248T I980K G85V V392G L973P L137H T351S R334W I444S V938G R792G R560T R555G L1339F D1305E P574H V1240G T1053I D58G G551D L1335P I918M F994C S945L L558S F1337V R810G D1152H G1247R P574S R766M D579G W1098R H949R F200I R352Q L1077P K1351E M244K L206W M1101K D1154G L375F N1303K R1066C E528D D110Y R347H R1070Q A800G P1021S S549K A1364V V392A damaging` (is supposed to affect protein function or structure) and 'probably damaging` (high confidence of affecting protein function or structure).
X
ABCC7 p.Pro841Arg 20059485:64:338
status: NEW
PMID: 21708286
[PubMed]
Fresquet F et al: "Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator a three-step biological approach to establishing a correlation between genotype and phenotype."
No.
Sentence
Comment
56
CFTR mutational analysis revealed a complex genotype: p.[Arg74Trp;Val201Met;Asp1270Asn] ϩ [Pro841Arg].
X
ABCC7 p.Pro841Arg 21708286:56:97
status: NEW97 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= CFTR Missense Mutation Biological Assay 3 JMD Month 2011, Vol. xx, No.
X
ABCC7 p.Pro841Arg 21708286:97:350
status: NEW109 Mixed Phenotype with P574S CFTR Variant The missense substitution p.[Pro574Ser] (P574S) lies within nucleotide-binding domain 1.
X
ABCC7 p.Pro841Arg 21708286:109:6
status: NEWX
ABCC7 p.Pro841Arg 21708286:109:58
status: NEWX
ABCC7 p.Pro841Arg 21708286:109:158
status: NEWX
ABCC7 p.Pro841Arg 21708286:109:212
status: NEWX
ABCC7 p.Pro841Arg 21708286:109:266
status: NEWX
ABCC7 p.Pro841Arg 21708286:109:283
status: NEWX
ABCC7 p.Pro841Arg 21708286:109:325
status: NEW119 Decreased Activity of K696R and P841R CFTR Mutants Two missense mutations, K696R and p.[Pro841Arg] (P841R), are situated within the cytoplasmic regulator domain of CFTR.
X
ABCC7 p.Pro841Arg 21708286:119:32
status: NEWX
ABCC7 p.Pro841Arg 21708286:119:88
status: NEWX
ABCC7 p.Pro841Arg 21708286:119:100
status: NEW122 Summary of the Patients` Data, Concerning Genotype, Phenotype, and Protein Dysfunction Patient no./sex/age at molecular diagnostics (years) Genotype Phenotype Protein dysfunctions Channel activity* Maturation† Intracellular localization‡ 1/F/3 p.[Leu102Pro] ϩ [Arg553X] Positive sweat test result, bacterial lung colonization, no pancreatitis ϩϩ ϩϩ ϩϩ 2/F/newborn p.[Phe508del] ϩ [Leu167Arg] Positive sweat test result, recurrent pancreatitis, no lung infection ϩϩ ϩϩ ϩϩ 3/F/3 p.[Asn1303Lys] ϩ [Pro574Ser] Normal sweat test result, asymptomatic ϩϩ ϩ ϩ 4/M/31 p.[Arg74Trp;Val201Met; Asp1270Asn] ϩ [Pro841Arg]; c.
X
ABCC7 p.Pro841Arg 21708286:122:731
status: NEW133 After using Western blot analysis (Figure 3B), the proportions of core-glycosylated protein for K696R and P841R appear insignificantly different from that of WT-CFTR (n ϭ 3, data not shown).
X
ABCC7 p.Pro841Arg 21708286:133:106
status: NEW134 Moreover, we observe by iodide efflux experiments that both mutations have similar functional consequence on CFTR activity: the maximum activation is reduced to 49.67% Ϯ 2.61% (n ϭ 4) for K696R and to 45.10% Ϯ 4.94% (n ϭ 4) for P841R (Figure 3C).
X
ABCC7 p.Pro841Arg 21708286:134:252
status: NEW161 B A calreticulin egremS475P calreticulin egremS475P WT F508del P574S CFTR C WT F508del P574S CFTR C B CFTR NaKATPase B CFTR NaKATPase C WT P574S *** WT P574S ***** 00 WT P574S 0 00 00 00 00 **** 00 WT P574S 0 00 00 00 00 0 50 100 WT % of maximal activation 0 50 100 WT % of maximal activationB/(B+C) (%) 100 0 200 300 400 500 B/(B+C) (%) 100 0 200 300 400 500 Figure 2.
X
ABCC7 p.Pro841Arg 21708286:161:106
status: NEW162 P574S amino acid substitution decreases CFTR protein maturation.
X
ABCC7 p.Pro841Arg 21708286:162:252
status: NEW192 One possible explanation could be that iodide effluxes are not sensitive enough to precisely evaluate the CFTR chloride channel activation process; notably, CFTR channel open probability could not be studied directly by this A B C P841R actin merge +TO-PRO K696R actin merge +TO-PRO P841R actin merge +TO-PRO K696R actin merge +TO-PRO % of maximal activation ** ** 0 50 100 WT K696R P841R % of maximal activation ** ** 0 50 100 WT K696R P841R % of maximal activation ** ** 0 50 100 WT K696R P841R WT F508del P841R K696R B CFTR NaKATPase C WT F508del P841R K696R B CFTR NaKATPase C Figure 3.
X
ABCC7 p.Pro841Arg 21708286:192:231
status: NEWX
ABCC7 p.Pro841Arg 21708286:192:283
status: NEWX
ABCC7 p.Pro841Arg 21708286:192:383
status: NEWX
ABCC7 p.Pro841Arg 21708286:192:437
status: NEWX
ABCC7 p.Pro841Arg 21708286:192:491
status: NEWX
ABCC7 p.Pro841Arg 21708286:192:508
status: NEWX
ABCC7 p.Pro841Arg 21708286:192:550
status: NEW193 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Pro841Arg 21708286:193:10
status: NEW209 Our results suggest a mild phenotype for the K696R and P841R CFTR mutants: the trafficking and maturation rates appear normal, whereas activation is approximately half reduced.
X
ABCC7 p.Pro841Arg 21708286:209:4
status: NEWX
ABCC7 p.Pro841Arg 21708286:209:55
status: NEW211 The variant K696R was isolated from a familial study, in which we did not find any other CFTR mutation.
X
ABCC7 p.Pro841Arg 21708286:211:284
status: NEW213 The P841R variant was carried by a patient with CBAVD, referred for pre-ICSI assessment; his spouse was heterozygous compound for p.[Phe508del].
X
ABCC7 p.Pro841Arg 21708286:213:4
status: NEWX
ABCC7 p.Pro841Arg 21708286:213:49
status: NEW214 His genotype was p.[Pro841Arg] ϩ [Arg74Trp;Val201Met; Asp1270Asn].
X
ABCC7 p.Pro841Arg 21708286:214:20
status: NEW215 The complex CFTR allele harboring three substitutions is considered responsible for a mild phenotype because a case of homozygosis has been reported for a patient exhibiting CBAVD, without severe CF features.22 Because the genotype of the patient results in CBAVD, we can deduce that P841R is either a mild or a severe mutation.
X
ABCC7 p.Pro841Arg 21708286:215:284
status: NEW216 Therefore, in the case of ICSI, it was decided by a pluridisciplinary antenatal staff that, if the resulting fetuses carried P841R and F508del alleles, this couple would be offered a therapeutic abortion, given the high risk of CF for the evaluated offspring.18 Our biological data are not fully in accordance with this conclusion because the P841R variant seems to not cause a severe CF phenotype because the CFTR protein could reach the plasma membrane and could be activated.
X
ABCC7 p.Pro841Arg 21708286:216:125
status: NEWX
ABCC7 p.Pro841Arg 21708286:216:343
status: NEW217 Taken together, these data strongly suggest that P841R is more likely to be a mild than a severe CF mutation.
X
ABCC7 p.Pro841Arg 21708286:217:49
status: NEW60 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= was presented.
X
ABCC7 p.Pro841Arg 21708286:60:350
status: NEW81 Summary of the Patients` Data, Concerning Genotype, Phenotype, and Protein Dysfunction Patient no./sex/age at molecular diagnostics (years) Genotype Phenotype Protein dysfunctions Channel activity* Maturation† Intracellular localization‡ 1/F/3 p.[Leu102Pro] ϩ [Arg553X] Positive sweat test result, bacterial lung colonization, no pancreatitis ϩϩ ϩϩ ϩϩ 2/F/newborn p.[Phe508del] ϩ [Leu167Arg] Positive sweat test result, recurrent pancreatitis, no lung infection ϩϩ ϩϩ ϩϩ 3/F/3 p.[Asn1303Lys] ϩ [Pro574Ser] Normal sweat test result, asymptomatic ϩϩ ϩ ϩ 4/M/31 p.[Arg74Trp;Val201Met; Asp1270Asn] ϩ [Pro841Arg]; c.
X
ABCC7 p.Pro841Arg 21708286:81:731
status: NEW110 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Pro841Arg 21708286:110:10
status: NEW158 Decreased Activity of K696R and P841R CFTR Mutants Two missense mutations, p.Lys696Arg (K696R) and p.Pro841Arg (P841R), are situated within the cytoplasmic regulator domain of CFTR.
X
ABCC7 p.Pro841Arg 21708286:158:32
status: NEWX
ABCC7 p.Pro841Arg 21708286:158:101
status: NEWX
ABCC7 p.Pro841Arg 21708286:158:112
status: NEW205 Our results suggest a mild phenotype for the K696R and P841R CFTR mutants: the trafficking and maturation rates appear normal, whereas activation is approximately half reduced.
X
ABCC7 p.Pro841Arg 21708286:205:55
status: NEW210 His genotype was p.[Pro841Arg] ϩ [Arg74Trp;Val201Met; Asp1270Asn].
X
ABCC7 p.Pro841Arg 21708286:210:20
status: NEW212 Therefore, in the case of ICSI, it was decided by a pluridisciplinary antenatal staff that, if the resulting fetuses carried P841R and F508del alleles, this couple would be offered a therapeutic abortion, given the high risk of CF for the evaluated offspring.18 Our biological data are not fully in accordance with this conclusion because the P841R variant seems to not cause a severe CF phenotype because the CFTR protein could reach the plasma membrane and could be activated.
X
ABCC7 p.Pro841Arg 21708286:212:125
status: NEWX
ABCC7 p.Pro841Arg 21708286:212:343
status: NEW
PMID: 18703181
[PubMed]
Brugnon F et al: "Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene."
No.
Sentence
Comment
0
CASE REPORT Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene Florence Brugnon, M.D.,a Frederic Bilan, Ph.D.,b Marie-Christine Heraud, M.D.,c Genevieve Grizard, Ph.D.,a Laurent Janny, M.D.,a and Isabelle Creveaux, M.D., Ph.Dd a CHU Clermont-Ferrand, Biologie du Developpement et de la Reproduction, CECOS, H^otel Dieu, Clermont Ferrand; b CHU Poitiers, Laboratoire de Genetique Cellulaire et Moleculaire, Universite de Poitiers, UFR Medecine-Pharmacie, Poitiers; c CHU Clermont Ferrand, Pediatrie A, H^otel Dieu; and d CHU Clermont Ferrand, Laboratoire de biochimie medicale et biologie moleculaire, Faculte de Medecine, Clermont Ferrand, France Objective: To document the phenotype associated with the p.[R74W;V201M;D1270N] and p.P841R mutations of cystic fibrosis transmembrane conductance regulator (CFTR) gene.
X
ABCC7 p.Pro841Arg 18703181:0:133
status: NEWX
ABCC7 p.Pro841Arg 18703181:0:953
status: NEWX
ABCC7 p.Pro841Arg 18703181:0:966
status: NEW3 Patient(s): A couple in which the man is carrier of the triple mutant p.[R74W;V201M;D1270N] allele in trans to p.P841R mutation and his spouse a heterozygous carrier for the severe p.F508del mutation of the CFTR gene, who became pregnant after intracytoplasmic sperm injection (ICSI) with twins.
X
ABCC7 p.Pro841Arg 18703181:3:113
status: NEW5 Main Outcome Measure(s): First report of a male phenotype associated with the p.P841R mutation.
X
ABCC7 p.Pro841Arg 18703181:5:80
status: NEW6 Result(s): The triple mutant p.[R74W;V201M;D1270N] allele associated with the unknown p.P841R mutations were detected in this man with congenital bilateral absence of the vas deferens, which may presume p.P841R as a severe mutation.
X
ABCC7 p.Pro841Arg 18703181:6:88
status: NEWX
ABCC7 p.Pro841Arg 18703181:6:205
status: NEW9 Conclusion(s): This case report documents for the first time a male phenotype associated with the p.P841R mutation and underlines the difficulties in counseling a man with congenital bilateral absence of the vas deferens carrying uncommon mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene before ICSI.
X
ABCC7 p.Pro841Arg 18703181:9:100
status: NEW12 Key Words: CFTR, [p.R74W;p.V201M;p.1270N], p.P841R, genetic counseling, ICSI, CBAVD Treatment by assisted reproductive technology (ART) of infertile men with congenital bilateral absence of the vas deferens (CBAVD) associated with mutations of the CFTR gene changed after the introduction of intracytoplasmic sperm injection (ICSI) with epididymal or testicular spermatozoa (1).
X
ABCC7 p.Pro841Arg 18703181:12:45
status: NEW16 The purpose of this case report is to describe and analyze the outcome of an infertile couple in which the man with CBAVD is carrier of rare mutations of the CFTR gene p.[R74W;V201M;D1270N] þ p.P841R and his spouse, a heterozygous carrier for F508del.
X
ABCC7 p.Pro841Arg 18703181:16:198
status: NEW17 To our knowledge, this is the first report that describes the phenotype of an infertile man with CBAVD carrying p.P841R.
X
ABCC7 p.Pro841Arg 18703181:17:114
status: NEW40 Results revealed that the man was a compound heterozygous carrier of the triple mutant p.[R74W;V201M;D1270N] allele and the unknown p.P841R mutation (Fig.
X
ABCC7 p.Pro841Arg 18703181:40:90
status: NEWX
ABCC7 p.Pro841Arg 18703181:40:134
status: NEW42 Segregation analysis of the man`s parents revealed that his father transmitted the CFTR p.P841R mutation and his mother, the complex allele p.[R74W;V201M;D1270N].
X
ABCC7 p.Pro841Arg 18703181:42:90
status: NEW43 To our knowledge the significance of CFTR p.P841R has never been described to date, and its functional significance is unknown.
X
ABCC7 p.Pro841Arg 18703181:43:44
status: NEW54 (a) p.D1270N mutation (3940 G>A); (b) p.R74W mutation (352 C>T); (c) p.P841R mutation (2854 C>G).
X
ABCC7 p.Pro841Arg 18703181:54:71
status: NEW65 Nevertheless, it is extremely difficult to predict the risks of inheritance of uncommon or newly identified mutations whose phenotype has never been described, such as the p.P841R mutation.
X
ABCC7 p.Pro841Arg 18703181:65:174
status: NEW66 The p.P841R mutation leads to the substitution of a proline for an arginine in exon 14a.
X
ABCC7 p.Pro841Arg 18703181:66:6
status: NEW82 The CBAVD phenotype described in homozygous p.[R74W;V201M;D1270N] patients (3) suggests that we can consider this triple mutant allele as mild.
X
ABCC7 p.Pro841Arg 18703181:82:145
status: NEW84 During genetic counseling before ICSI, the couple was given explanations concerning the high risk of CF for the children if both p.F508del and p.P841R were inherited, respectively, from their mother and father, and the risk of CBAVD if p.[R74W;V201M;D1270N] and p.F508del were inherited.
X
ABCC7 p.Pro841Arg 18703181:84:145
status: NEW88 If the fetus were found to be a carrier of p.P841R and p.F508del, the couple was offered therapeutic abortion, given the high risk of CF for the offspring.
X
ABCC7 p.Pro841Arg 18703181:88:45
status: NEW39 Results revealed that the man was a compound heterozygous carrier of the triple mutant p.[R74W;V201M;D1270N] allele and the unknown p.P841R mutation (Fig. 1) and his spouse was a heterozygous carrier for p.F508del.
X
ABCC7 p.Pro841Arg 18703181:39:134
status: NEW41 To our knowledge the significance of CFTR p.P841R has never been described to date, and its functional significance is unknown.
X
ABCC7 p.Pro841Arg 18703181:41:44
status: NEW52 (a) p.D1270N mutation (3940 G>A); (b) p.R74W mutation (352 C>T); (c) p.P841R mutation (2854 C>G).
X
ABCC7 p.Pro841Arg 18703181:52:71
status: NEW63 Nevertheless, it is extremely difficult to predict the risks of inheritance of uncommon or newly identified mutations whose phenotype has never been described, such as the p.P841R mutation.
X
ABCC7 p.Pro841Arg 18703181:63:174
status: NEW64 The p.P841R mutation leads to the substitution of a proline for an arginine in exon 14a.
X
ABCC7 p.Pro841Arg 18703181:64:6
status: NEW86 If the fetus were found to be a carrier of p.P841R and p.F508del, the couple was offered therapeutic abortion, given the high risk of CF for the offspring.
X
ABCC7 p.Pro841Arg 18703181:86:45
status: NEW